Table 1 Clinical outcome of our study cohort
Characteristics n (%) if not labelled differently | COVID-19 positive* | COVID-19 negative* | p-value | |||
|---|---|---|---|---|---|---|
Total (n = 72) | With pneumonia in CT (n = 61) | Total (n = 147) | With pneumonia in CT (n = 50) | Total | With Pneumonia | |
Clinical course | ||||||
Hospitalization | 67 (93.1) | 60 (98.4) | 107 (72.8) | 45 (90.0) | 0.0003 | 0.089 |
Duration of hospitalization in days** (mean ± SEM) | 10.4 ± 1.0 | 11.3 ± 1.1 | 7.5 ± 0.5 | 9.8 ± 1.0 | 0.019 | 0.404 |
Admission to ICU | 18 (26.9) | 18 (30.0) | 15 (14.0) | 12 (26.7) | 0.047 | 0.828 |
Hospitalization to ICU in days (mean ± SEM) | 1.8 ± 0.6 | 1.8 ± 0.6 | 1.7 ± 0.8 | 1.9 ± 0.9 | 0.474 | 0.500 |
Duration of intensive care in days** (mean ± SEM) | 10.6 ± 2.3 | 10.6 ± 2.3 | 7.3 ± 1.5 | 8.0 ± 1.6 | 0.367 | 0.550 |
Outcome | ||||||
Discharged | 53 (79.1) | 46 (76.7) | 93 (86.9) | 37 (82.2) | ||
Still hospitalized*** | 11 (16.4) | 11 (18.3) | 11 (10.3) | 6 (13.3) | ||
Dead | 3 (4.5) | 3 (5.0) | 3 (2.8) | 2 (4.4) | ||
No hospitalization | 5 (6.9) | 1 (1.6) | 40 (27.2) | 5 (10.0) | ||